Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Chinese Patent Office
Mallinckrodt
Baxter
Fuji
Harvard Business School
Express Scripts
Dow
Healthtrust
Cantor Fitzgerald

Generated: October 19, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,361,500

« Back to Dashboard

Which drugs does patent 8,361,500 protect, and when does it expire?


Patent 8,361,500 protects VARUBI and is included in one NDA.

This patent has sixteen patent family members in ten countries.

Summary for Patent: 8,361,500

Title:Tablet formulations containing 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one salts and tablets made therefrom
Abstract: Pharmaceutical formulations containing a salt of (5S,8S)-8-[{(1R)-1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-ph- enyl-1,7-diazaspiro[4.5]decan-2-one, represented by Formula I, which are suitable for forming into a tablet dosage form, as well as tablet dosage forms are disclosed. Disclosed also are methods of treatment utilizing such dosage forms.
Inventor(s): Qiu; Zhihui (Bridgewater, NJ), Cho; Wing-Kee Philip (Princeton, NJ), Zhao; Na (Belle Mead, NJ), Wong; Victor Ming-she (Berkeley Heights, NJ)
Assignee: Opko Health, Inc. (Miami, FL)
Application Number:12/531,966
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Tesaro Inc
VARUBI
rolapitant hydrochloride
TABLET;ORAL206500-001Sep 1, 2015RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,361,500

PCT Information
PCT FiledMarch 20, 2008PCT Application Number:PCT/US2008/003653
PCT Publication Date:October 02, 2008PCT Publication Number: WO2008/118331

International Patent Family for Patent: 8,361,500

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina065802► Subscribe
Canada2681465► Subscribe
Chile2008000819► Subscribe
European Patent Office2136793► Subscribe
Spain2406934► Subscribe
Japan2010522173► Subscribe
Japan2013216694► Subscribe
Japan2015108023► Subscribe
Japan5442459► Subscribe
Japan5763134► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Julphar
Fish and Richardson
Boehringer Ingelheim
Federal Trade Commission
Express Scripts
Teva
UBS
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot